Antibiotic Usage Guidelines in Hospital
|
|
- Aileen Gordon
- 6 years ago
- Views:
Transcription
1 SUPPLEMENT TO JAPI december VOL Antibiotic Usage Guidelines in Hospital Camilla Rodrigues * Use of surveillance data information of Hospital antibiotic policy guidelines from Hinduja Hospital. The data presented includes only the top few isolated from the respective cultures at Hinduja Hospital and intends to represent at least 80 of the responsible for a given infection. The antibiotic susceptibilities are obtained as per available microbiology records, from Hinduja Hospital. Antibiotic with at least 80 cover for most common should be selected as empenic choice. Drug susceptibility is mentioned as based on data collected from January to August 2009, at Hinduja Hospital. Steps to Follow the Protocols Identify the type of infection bloodstream, respiratory, intra-abdominal or urinary tract, o Define the location ICU or floor patient o Accordingly refer the respective chart Identify the patient type based on described parameters Type 1, Type 2 or Type 3. Refer to the empiric column for that patient type. This will give you the protocol drug to start If a column has more than one drug option Choose the drug showing better susceptibility data in the left hand side table OR Doctor s discretion advised Send respective cultures before starting antibiotic Once culture / sensitivity report available: Presumptive antibiotic may require to be changed Consult Microbiology / ID physician to decide the choice of antibiotic (based on narrowest spectrum antibiotic which covers the pathogen isolated) In all cases physician s discretion is advised based on patient condition * Consultant Microbiologist, PD Hinduja Hospital, Mahim, Mumbai Hospital surveillance data (January-09 to August 09) Most common (n=124) 1 Klebsiella (n=44) 2 Escherichia coli (n=31) Blood Stream Infections - ICU Validity of these data: August- 35 Colistin (100) (96) (92) Amikacin (82) Pip-Taz/Cef- Sulb (75) 25 Colistin (100) Imipenem/ (91) /Amikacin (84 ) Pip - Taz /Cef- Sulb (71) 3 Pseudomonas 21 Colistin (100) aeruginosa (n=26) Imipenem (23) /Pip - Taz / Cef- Sulb / Amikacin (19) 4 Acinetobacter 11 Colistin (100) baumanii (n=14) Imipenem (43) Amikacin (36) 5 Enterobacter (n=9) 7 Colistin (100) / Pip-Taz / / Cef-Sulb /Amikacin (89) contact with health Contact with health Long hospitalization (e.g. last last with multiple within last exposure to group 2 carbapenems: Colistin - until culture report Consult Microbiology /ID Physician to decide on choice of
2 52 SUPPLEMENT TO JAPI december VOL. 58 Urinary Tract Infections - ICU (January August 09) (n=115) (n=47) (n=28) 3 Pseudomonas aeruginosa (n=27) Validity of these data: August- 41 Colistin / (96) Amikacin (91) Pip - Taz (87) Netilmicin (85) Cef-Sulb(83) 24 Colistin (96) Amikacin / (78) 23 Colistin (100) Imipenem (47) Pip- Taz / Cef- Sulb / (41) 4 Enterococcus (n=7) 6 Vancomycin / linezolid (100) Co-amoxiclav (57) contact with health Contact with health Long hospitalization (e.g. last last within last exposure to group 2 carbapenems: Colistin - until culture report Consult Microbiology / ID Physician to decide on choice of Respiratory Tract Infections - ICU (January-09 to October 09) (n=224) 1 Pseudomonas aeruginosa (n=90) (n=64) 3 Acinetobacter baumanii (n=20) 40 Colistin (100) Cef- Sulb (49) Amikacin (44) 29 Colistin (97) Tigecycline (92) Imipenem (92) (92) Amikacin (83) 9 Colistin (100) Tigecycline (55) Imipenem (25) (15) 4 Enterobacter (n=ll) 5 Colistin / Tigecycline (100) /Amikacin (73) contact with health Contact with health Long hospitalization (e.g. last last within last / Coamoxiclav + Macrolide + Macrolide + Newer Colistin + Newer Consult Microbiology /ID Physician to decide on choice of
3 SUPPLEMENT TO JAPI december VOL Intra - Abdominal Infections - ICU (January-09 - October 09) (n=29) (n=10) 2 Enterococcus (n=6) 3 Klebsiella (n=5) 4 Enterobacter (n=4) 34 / Colistin / Tigecycline (100) (97) Amikacin / Cef- sulb (80) 21 Vancomycin / linezolid (100) Chloramphenicol (83) 17 Colistin (100) (83) Tigecycline / (80) 14 / Pip -Taz / / Cef- Sulb / Amikacin / Ciprofloxacin / Cotrimoxazole / Colistin (100) Tigecycline / Gentamicin (75) 5 Pseudomonas 10 Colistin (100) aeruginosa (n=3) Pip-Taz / Cef- sulb (33) contact with health Contact with health Long hospitalization (e.g. last last within last Cefuroxime + Tigecycline Sulbactam Colistin + Co-amoxiclav Consult Microbiology / ID Physician to decide on choice of (January-09 to August 09) (n=52) (n=29) (n=15) Blood Stream Infections - Floor Validity of these data: August- 56 / Colistin / Amikacin (97) (90) Pip -Taz / Cef - Sulb (86) 29 / Colistin / (100) Amikacin (93) Pip -Taz / Cef- Sulb (73) contact with health Contact with health Long hospitalization (e.g. last last within last Cefoperazone - / - Tazobactam ± Amikacin Consult Microbiology / ID Physician to decide on choice of
4 54 SUPPLEMENT TO JAPI december VOL. 58 Urinary Tract Infections - Floor (January-09 - August 09) (n=369) 1 Escherichia coii (n=231) Validity of these data: August- 63 (96) Amikacin (91) Pip-Taz/cefsulb(92) 2 Pseudomonas 15 Colistin (100) aeruginosa (n=56) Imipenem (39) (37) 3 Klebsiella (n=47) 13 Colistin (96) Imipenem/ (91) Amikacin (80) 4 Enterobacter (n=9) 2 Colistin (100) (78) Pip-Taz/Cef- Sulb (67) 5 Enterococcus (n=9) 2 Vancomycin / linezolid (100) contact with health Contact with health Long hospitalization (e.g. last last within last imm unodeficiency. Cefoperazone exposure to group 2 carbapenems: Colistin - until culture report Consult Microbiology / ID Physician to decide on choice of Respiratory Tract Infections - Floor (January-09 to October 09) (n=104) 1 Pseudomonas aeruginosa (n=37) (n=35) 3 Enterobacter (n=8) 4 Streptococcus (n=6) 5 Escherichia coli (n=5) 36 Colistin (94) Imipenem (78) Amikacin/Cef - sulb (73) Pip-Taz / / Ciprofloxacin (70) 34 Colistin (100 ) (96) Tigecycline (92) Amikacin (86) 8 / Pip-Taz /Cef - sulb Amikacin (100) Gentamicin /Tigecycline (88) 6 Ampicillin/ / Erythromycin (100) 5 / Pip-Taz / Cef- sulb Amikacin /Tigecycline / Colistin / (100) Gentamicin (80) contact with health Contact with health Long hospitalization (e.g. last last within last imm unodeficiency. / Coamoxiclav + Macrolide + Macrolide + Newer Colistin + Newer Consult Microbiology /ID Physician to decide on choice of
5 SUPPLEMENT TO JAPI december VOL Intra - Abdominal Infections - Floor (January-09 to October 09) (n=66) (n=34) 2 Enterococcus (n=12) 3 Klebsiella (n=9) 4 Pseudomonas aeruginosa (n=4) 5 Enterobacter (n=3) 52 / Colistin (100) / Amikacin / Tigecycline (97) 18 Vancomycin (100) 14 Colistin (100) Amikacin (88) (77) (75), Tigecycline (55) 6 Pip-Taz /Gentamicin / Colistin (100) / Cef-sulb /Netilmicin /Amikacin (75) 5 / Pip -Taz / Cef - Sulb / / Ciprofloxacin / Tigecycline / Colistin (100) contact with health Contact with health Long hospitalization (e.g. last last within last Cefuroxime + Tigecycline Sulbactam Colistin + Co-amoxiclav Consult Microbiology /ID Physician to decide on choice of Antibiotic Prophylaxis for Surgery * Procedure Antibiotic Clean surgeries (example: elective hernia repair, breast surgeries) Orthopedic surgery Cardiovascular / vascular surgery Neurosurgery Ophthalmic surgery Topical quinolone. Immediate pre operative betadine, Systemic Head, neck and ENT surgery Gastroduodenal Cefuroxime / Cefazolin Appendicular / Colorectal surgery Biliary Abdominal / Vaginal hysterectomy / Caesarian section Urologic surgery Cefuroxime / Cefazolin and Cefuroxime / Cefazolin Cefuroxime (or as guided by urine culture) Antibiotic Dosing Drug Standard dose Weight based dose Cefazolin < 80 kg: 1 gm > 80 kg: 2 gm mg/kg/ dose Duration for bolus injection (infusion) 3-5 mins (20-60 mins) Cefuroxime 1.5 gm 50 mg/kg 3-5 mins (20-60 mins) gm 15 mg/kg initial dose (7.5 mg/kg subsequent doses) (30-60 mins) * As per existing Infection Control Book - Hinduja Hospital
6 56 SUPPLEMENT TO JAPI december VOL. 58 Standard Dosages of Commonly Used Drugs * Antibiotic Colistin Imipenem/cilastatin Piperacilin Tazobactam Ampicillin - Sulbactam Doses <60 Kg : 50,000-75,000 Units/Kg daily in 3 divided doses >60 Kg : 1-2 million units every 8hrs 1-2 gm daily (in 3-4 divided doses) Less sensitive organism: upto 50 mg/ kg daily (max 4 gm daily) in 3-4 divided doses. 500 mg every 8 hrs, dose doubled to 1 gm every 8 hours in hospital-acquired pneumonia, peritonitis, septicemia and infections in neutropenic patients 1 gm once daily 12 g piperacillin /1.5 g tazobactam given in divided doses every 6 or 8 hours. Doses as high as 18g piperacillin /2.25 g tazobactam per day in divided doses can be used in infections. 1.5 g (1 g ampicillin as the sodium salt plus 0.5 g sulbactam as the sodium salt) to 3 g (2 g ampicillin as the sodium salt plus 1 g sulbactam as the sodium salt) every six hours Sulbactam Cefoperazone Sulbactam(l:l) ( available as 1+1 gm OR 2+2 gm forms) - 2gm to 4gm per day IM or IV, in equally divided doses every 12h. Cefoperazone Sulbactam(2:l) ie. 3 gm : 1.5 gm 12 h Co Amoxiclav 500 mg every 12 hours or 250 mg every 8 hours 1 gm every 8 hrs to 1 gm every 6hrs in more serious infection Tigecycline >18 yrs : initially loomg, then 50mg every 12 hrs for 5-14 days lgm daily OR 2-4gm daily in infections Cefuroxime Ofloxacin Oral (cefuroxime axetil): mg twice daily for 10 days 1.5 gm every 6-8 hrs in infection 200 to 400 mg every 12 hours 200mg over at least 30 mins once to twice daily Antibiotic Ciprofloxacin Moxifloxacin Levofloxacin rfloxacin Linezolid Vancomycin Teicoplanin Amikacin Erythromycin Clarithromycin Azithromycin Nitrofurantoin Doses 250 to 500 mg twice daily 200 mg over mins OR 400mg over 60 mins - twice daily Oral / 400 mg (orally or as an intravenous infusion) once every 24 hours 250, 500 or 750 mg every 24 hours 500 mg once or twice daily - over at least 60 mins 400 mg twice daily Oral / intravenous: 600 mg every 12hrs (if i.v - infusion over mins) 2 gm given as 500 mg 6 hourly or 1 gm every 12 hrs; elderly over 65 yrs, 500 mg every 12 hrs or 1 gm once daily Severe infection lomg/kg/day every 12 hours for first 3 doses, then lomg/kg/day iv once daily 15 mg/kg over 1 hour loading dose and 7.5 mg/kg 3 to 4 tomes a day maintainance dose 15 mg/kg daily in 2 divided doses; increased to 22.5 mg/kg daily in 3 divided doses in infection; maximum 1.5 gm daily for upto 10 days (max cumulative dose 15 gm) 500 mg four times a day Severe infection, 50 mg/kg daily by continuous infusion or in divided doses every 6 hrs; mild infection (if oral not possible) : 25 mg/kg daily 250 to 500 mg twelve hourly Intravenous / 500 mg once daily for 3 days or 500 mg on first day then 250 mg once daily for 4 days 50 mg every 6 hrs with food; chronic recurrent infection : 100 mg every 6 hrs with food * All dosages mentioned are from British National Formulary 2008 / respective product monographs, and are for healthy adult. Necessary adjustments to be for hepatic / renal insufficiency, pediatric patients and as per clinician s discretion. Please refer product literature for dosages of drugs not listed here.
PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS
PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS The current supply of piperacillin- tazobactam should be reserved f Microbiology / Infectious Diseases approval and f neutropenic sepsis, severe sepsis
More informationMercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016
Mercy Medical Center Des Moines, Iowa Department of Pathology Microbiology Department Antibiotic Susceptibility January December 2016 These statistics are intended solely as a GUIDE to choosing appropriate
More informationRational management of community acquired infections
Rational management of community acquired infections Dr Tanu Singhal MD, MSc Consultant Pediatrics and Infectious Disease Kokilaben Dhirubhai Ambani Hospital, Mumbai Why is rational management needed?
More informationConcise Antibiogram Toolkit Background
Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions
More informationWorkplan on Antibiotic Usage Management
IMPACT Forum: Antibiotic Guideline in Perspective Workplan on Antibiotic Usage Management Dr. Raymond Yung Consultant Microbiologist PYNEH 20 April 2002 May 2002 Dr. Raymond Yung 1 Objective 1. Heighten
More informationAntimicrobial Susceptibility Patterns
Antimicrobial Susceptibility Patterns KNH SURGERY Department Masika M.M. Department of Medical Microbiology, UoN Medicines & Therapeutics Committee, KNH Outline Methodology Overall KNH data Surgery department
More information2015 Antibiotic Susceptibility Report
Citrobacter freundii Enterobacter aerogenes Enterobacter cloacae Escherichia coli Haemophilus influenzenza Klebsiella oxytoca Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa Serratia marcescens
More information1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient
1 Chapter 79, Self-Assessment Questions 1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient with normal renal function is: A. Trimethoprim-sulfamethoxazole B. Cefuroxime
More informationNHS Dumfries And Galloway. Surgical Prophylaxis Guidelines
NHS Dumfries And Galloway Surgical Prophylaxis Guidelines The aim of surgical prophylaxis is to reduce rates of surgical site and health-care associated infections and so reduce surgical morbidity and
More information2016 Antibiotic Susceptibility Report
Fairview Northland Medical Center and Elk River, Milaca, Princeton and Zimmerman Clinics 2016 Antibiotic Susceptibility Report GRAM-NEGATIVE ORGANISMS 2016 Gram-Negative Non-Urine The number of isolates
More informationChildrens Hospital Antibiogram for 2012 (Based on data from 2011)
Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical
More informationEUCAST recommended strains for internal quality control
EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC
More informationSuggestions for appropriate agents to include in routine antimicrobial susceptibility testing
Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory
More information21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review
(1) Have all important studies/evidence of which you are aware been included in the application? Yes No Please provide brief comments on any relevant studies that have not been included: (2) For each of
More informationGENERAL NOTES: 2016 site of infection type of organism location of the patient
GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered
More informationجداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی
جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی ویرایش دوم بر اساس ed., 2017 CLSI M100 27 th تابستان ۶۹۳۱ تهیه
More informationThese recommendations were approved for use by the Pharmaceutical and Therapeutics Committee, RCWMCH on 1 February 2017.
Antibiotic regimens for suspected hospital-acquired infection (HAI) outside the Paediatric Intensive Care Unit at Red Cross War Memorial Children s Hospital (RCWMCH) Lead author: Brian Eley Contributing
More informationRoutine internal quality control as recommended by EUCAST Version 3.1, valid from
Routine internal quality control as recommended by EUCAST Version.1, valid from 01-01-01 Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus
More informationInteractive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe
Interactive session: adapting to antibiogram Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe Case 1 63 y old woman Dx: urosepsis? After 2 d: intermediate result: Gram-negative bacilli Empiric antibiotic
More informationAntibiotic Stewardship Program (ASP) CHRISTUS SETX
Antibiotic Stewardship Program (ASP) CHRISTUS SETX Program Goals I. Judicious use of antibiotics Decrease use of broad spectrum antibiotics and deescalate use based on clinical symptoms Therapeutic duplication:
More informationUnderstanding the Hospital Antibiogram
Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital
More informationNational Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults
National Clinical Guideline Centre Antibiotic classifications Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults Clinical guideline 191 Appendix N 3 December 2014
More informationCost high. acceptable. worst. best. acceptable. Cost low
Key words I Effect low worst acceptable Cost high Cost low acceptable best Effect high Fig. 1. Cost-Effectiveness. The best case is low cost and high efficacy. The acceptable cases are low cost and efficacy
More informationPerichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV
Empiric Antibiotics for Pediatric Infections Seen in ED NOTE: Choice of empiric antibiotic therapy must take into account local pathogen frequency and resistance patterns, individual patient characteristics,
More informationPRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE
PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE Global Alliance for Infection in Surgery World Society of Emergency Surgery (WSES) and not only!! Aims - 1 Rationalize the risk of antibiotics overuse
More informationAntibiotic Updates: Part II
Antibiotic Updates: Part II Fredrick M. Abrahamian, DO, FACEP, FIDSA Health Sciences Clinical Professor of Emergency Medicine David Geffen School of Medicine at UCLA Los Angeles, California Financial Disclosures
More information* gender factor (male=1, female=0.85)
Usual Doses of Antimicrobials Typically Not Requiring Renal Adjustment Azithromycin 250 500 mg Q24 *Amphotericin B 1 3-5 mg/kg Q24 Clindamycin 600 900 mg Q8 Liposomal (Ambisome ) Doxycycline 100 mg Q12
More informationIntrinsic, implied and default resistance
Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been
More informationAntimicrobial Susceptibility Testing: Advanced Course
Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to
More informationStanding Orders for the Treatment of Outpatient Peritonitis
Standing Orders for the Treatment of Outpatient Peritonitis 1. Definition of Peritonitis: a. Cloudy effluent. b. WBC > 100 cells/mm3 with >50% polymorphonuclear (PMN) cells with minimum 2 hour dwell. c.
More informationSHC Surgical Antimicrobial Prophylaxis Guidelines
SHC Surgical Antimicrobial Prophylaxis Guidelines I. Purpose/Background This document is based upon the 2013 consensus guidelines from American Society of Health-System Pharmacists (ASHP), the Infectious
More informationGUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS
Version 3.1 GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS Date ratified June 2008 Updated March 2009 Review date June 2010 Ratified by Authors Consultation Evidence base Changes
More informationAntibiotic Abyss. Discussion Points. MRSA Treatment Guidelines
Antibiotic Abyss Fredrick M. Abrahamian, D.O., FACEP, FIDSA Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical Center Sylmar, California
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The
More informationUpdate on Resistance and Epidemiology of Nosocomial Respiratory Pathogens in Asia. Po-Ren Hsueh. National Taiwan University Hospital
Update on Resistance and Epidemiology of Nosocomial Respiratory Pathogens in Asia Po-Ren Hsueh National Taiwan University Hospital Ventilator-associated Pneumonia Microbiological Report Sputum from a
More information2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine
2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose
More informationStanding Orders for the Treatment of Outpatient Peritonitis
Standing Orders for the Treatment of Outpatient Peritonitis 1. Definition of Peritonitis: a. Cloudy effluent. b. WBC > 100 cells/mm3 with >50% polymorphonuclear (PMN) cells with minimum 2 hour dwell. c.
More informationAppropriate antimicrobial therapy in HAP: What does this mean?
Appropriate antimicrobial therapy in HAP: What does this mean? Jaehee Lee, M.D. Kyungpook National University Hospital, Korea KNUH since 1907 Presentation outline Empiric antimicrobial choice: right spectrum,
More informationAntimicrobial Susceptibility Testing: The Basics
Antimicrobial Susceptibility Testing: The Basics Susan E. Sharp, Ph.D., DABMM, FAAM Director, Airport Way Regional Laboratory Director, Regional Microbiology and Molecular Infectious Diseases Laboratories
More informationVCH PHC SURGICAL PROPHYLAXIS RECOMMENDATIONS
VCH PHC SURGICAL PROPHYLAXIS RECOMMENDATIONS CARDIAC Staphylococcus aureus, S. epidermidis, except for For patients with known MRSA colonization, recommend decolonization with Antimicrobial Photodynamic
More information3/20/2011. Code 215 of Hammurabi: If a physician performed a major operation on
The Good Antibiotics: the Good, the Bad and the Ugly John P. Cello, MD Professor of Medicine and Surgery, University of California, San Francisco Most organisms can be readily identified by culture, special
More information2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose
2017 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility
More informationThe Basics: Using CLSI Antimicrobial Susceptibility Testing Standards
The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards Janet A. Hindler, MCLS, MT(ASCP) UCLA Health System Los Angeles, California, USA jhindler@ucla.edu 1 Learning Objectives Describe information
More information2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital
2010 ANTIBIOGRAM University of Alberta Hospital and the Stollery Children s Hospital Medical Microbiology Department of Laboratory Medicine and Pathology Table of Contents Page Introduction..... 2 Antibiogram
More informationAntimicrobial Pharmacodynamics
Antimicrobial Pharmacodynamics November 28, 2007 George P. Allen, Pharm.D. Assistant Professor, Pharmacy Practice OSU College of Pharmacy at OHSU Objectives Become familiar with PD parameters what they
More informationAntibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting
Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria
More informationScottish Medicines Consortium
Scottish Medicines Consortium tigecycline 50mg vial of powder for intravenous infusion (Tygacil ) (277/06) Wyeth 9 June 2006 The Scottish Medicines Consortium (SMC) has completed its assessment of the
More informationManagement of Hospital-acquired Pneumonia
Management of Hospital-acquired Pneumonia Adel Alothman, MB, FRCPC, FACP Asst. Professor, COM, KSAU-HS Head, Infectious Diseases, Department of Medicine King Abdulaziz Medical City Riyadh Saudi Arabia
More informationA retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya
A retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya LU Edirisinghe 1, D Vidanagama 2 1 Senior Registrar in Medicine, 2 Consultant Microbiologist,
More informationThe relevance of Gram-negative pathogens for public health situation in India
The relevance of Gram-negative pathogens for public health situation in India Dr. Sanjay Bhattacharya MD, DNB, DipRCPath, FRCPath, CCT (UK) Consultant Microbiologist Tata Medical Center www.tmckolkata.com
More informationOther Beta - lactam Antibiotics
Other Beta - lactam Antibiotics Assistant Professor Dr. Naza M. Ali Lec 5 8 Nov 2017 Lecture outlines Other beta lactam antibiotics Other inhibitors of cell wall synthesis Other beta-lactam Antibiotics
More informationNational Antimicrobial Prescribing Survey
Indication documented Surgical prophylaxis >24 hrs Allergy mismatch Microbiology mismatch Incorrect route Incorrect dose/frequency Incorrect duration Therapeutic Guidelines Local guidelines * Non-compliant
More informationMisericordia Community Hospital (MCH) Antimicrobial Stewardship Report. July December 2013 Second and Third Quarters 2014
H e a l i n g t h e B o d y E n r i c h i n g t h e M i n d N u r t u r i n g t h e S o u l Misericordia Community Hospital (MCH) Antimicrobial Stewardship Report July December 213 Second and Third Quarters
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01
More informationInt. J. Pharm. Sci. Rev. Res., 28(2), September October 2014; Article No. 06, Pages: 28-34
Research Article A Study on Evaluation of Appropriateness of Antibiotics Used in the Intensive Care Unit Settings of a Tertiary Care Teaching Hospital Balaji S 1, Karthik S 2, Madhuri Pasupuleti 3, G Kannan*
More informationAntimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018
Antimicrobial Update Alison MacDonald Area Antimicrobial Pharmacist NHS Highland alisonc.macdonald@nhs.net April 2018 Starter Questions Setting the scene... What if antibiotics were no longer effective?
More informationAntimicrobial Stewardship Program: Local Experience
Antimicrobial Stewardship Program: Local Experience Dr. WU Tak Chiu Associate Consultant Division of Infectious Diseases Department of Medicine Queen Elizabeth Hospital 18th January 2011 QUEEN ELIZABETH
More information- the details, where possible, of the antibiotic products these companies supply or have supplied.
Under the Freedom of Information Act 2000 please could you provide me with a list of all companies currently supplying antibiotics - or that have supplied antibiotics in the last three years - to Royal
More informationOBSTETRICS & GYNAECOLOGY. Penicillin G 5 million units IV ; followed by 2.5 million units 4hourly upto delivery
OBSTETRICS & GYNAECOLOGY A.OBSTETRICS Infection/Condition/likely organism Intrapartum Group B Streptococcal (GBS) infection; positive mothers Suggested treatment Preferred Penicillin G 5 million units
More informationSolution Title: Antibiotic Stewardship: A Journey Toward the Triple Aim
Solution Title: Antibiotic Stewardship: A Journey Toward the Triple Aim Program/Project Description, including Goals What was the problem to be solved? How was it identified? What baseline data existed?
More informationGuidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults)
Guidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults) Community Acquired Pneumonia Community Acquired Pneumonia 1) Is it pneumonia? ie new symptoms and signs of
More informationApproach to pediatric Antibiotics
Approach to pediatric Antibiotics Gassem Gohal FAAP FRCPC Assistant professor of Pediatrics objectives To be familiar with common pediatric antibiotics o Classification o Action o Adverse effect To discus
More information2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital
2009 ANTIBIOGRAM University of Alberta Hospital and the Stollery Childrens Hospital Division of Medical Microbiology Department of Laboratory Medicine and Pathology 2 Table of Contents Page Introduction.....
More informationJanuary 2014 Vol. 34 No. 1
January 2014 Vol. 34 No. 1. and Minimal Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) roth dilution: cation-adjusted Mueller-Hinton
More information2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time)
Key words I μ μ μ μ μ μ μ μ μ μ μ μ μ μ II Fig. 1. Microdilution plate. The dilution step of the antimicrobial agent is prepared in the -well microplate. Serial twofold dilution were prepared according
More informationDr. Shaiful Azam Sazzad. MD Student (Thesis Part) Critical Care Medicine Dhaka Medical College
Dr. Shaiful Azam Sazzad MD Student (Thesis Part) Critical Care Medicine Dhaka Medical College INTRODUCTION ICU acquired infection account for substantial morbidity, mortality and expense. Infection and
More informationHelp with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST
Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to
More informationAntimicrobial susceptibility
Antimicrobial susceptibility PATTERNS Microbiology Department Canterbury ealth Laboratories and Clinical Pharmacology Department Canterbury District ealth Board March 2011 Contents Preface... Page 1 ANTIMICROBIAL
More informationCompliance of manufacturers of AST materials and devices with EUCAST guidelines
Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The
More informationBacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching Hospital, Bengaluru, India
ISSN: 2319-7706 Volume 4 Number 11 (2015) pp. 731-736 http://www.ijcmas.com Original Research Article Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching
More informationEinheit für pädiatrische Infektiologie Antibiotics - what, why, when and how?
Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how? Andrea Duppenthaler andrea.duppenthaler@insel.ch Limping patient local pain swelling tenderness warmth fever acute Osteomyelitis
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Reference Number: CP.HNMC.04 Effective Date: 07.01.17 Last Review Date: 02.18 Line of Business: Medicaid - HNMC Revision Log See Important Reminder at the end of this policy for important
More informationIntro Who should read this document 2 Key practice points 2 Background 2
Antibiotic Guidelines: Obstetric Anti-Infective Prescribing Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): Kelly Alexander / Frances Garraghan
More informationAntibiotic Prophylaxis in Spinal Surgery Antibiotic Guidelines. Contents
Antibiotic Prophylaxis in Spinal Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): Authors Division: DCSS & Tertiary Medicine Unique
More informationGuidelines for Antimicrobial treatment for treatment of confirmed infections adults
Guidelines for Antimicrobial treatment for treatment of confirmed infections adults This guideline gives recommendations for treatment of confirmed infections in adults for children please see the Paediatric
More informationPrinciples of Infectious Disease. Dr. Ezra Levy CSUHS PA Program
Principles of Infectious Disease Dr. Ezra Levy CSUHS PA Program I. Microbiology (1) morphology (e.g., cocci, bacilli) (2) growth characteristics (e.g., aerobic vs anaerobic) (3) other qualities (e.g.,
More information2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services
2015 Antibiogram Red Deer Regional Hospital Central Zone Alberta Health Services Introduction. This antibiogram is a cumulative report of the antimicrobial susceptibility rates of common microbial pathogens
More informationMeasure Information Form
Release Notes: Measure Information Form Version 3.0b **NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE** Measure Set: Pneumonia (PN) Performance Measure Identifier: Measure Information Form
More informationRecommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland
Recommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland A report by the Hospital Antimicrobial Stewardship Working Group, a subgroup of the
More informationSimilar to Penicillins: -Chemically. -Mechanism of action. -Toxicity.
Similar to Penicillins: -Chemically. -Mechanism of action. -Toxicity. Cephalosporins are divided into Generations: -First generation have better activity against gram positive organisms. -Later compounds
More informationAntimicrobial Stewardship Strategy: Antibiograms
Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide
More informationRCH antibiotic susceptibility data
RCH antibiotic susceptibility data The following represent RCH antibiotic susceptibility data from 2008. This data is used to inform antibiotic guidelines used at RCH. The data includes all microbiological
More informationAvailable online at ISSN No:
Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2017, 6(4): 36-42 Comparative Evaluation of In-Vitro Doripenem Susceptibility with Other
More information10/13/14. Low: not well absorbed. Good: [blood and tissue] < than if given IV. High: > 90% absorption orally
Low: not well absorbed PO agent not for serious infection nitrofurantoin Good: [blood and tissue] < than if given IV [Therapeutic] in excess of [effective] eg. cephalexin High: > 90% absorption orally
More informationStudies on Antimicrobial Consumption in a Tertiary Care Private Hospital, India
Human Journals Research Article April 2016 Vol.:6, Issue:1 All rights are reserved by Zarine Khety et al. Studies on Antimicrobial Consumption in a Tertiary Care Private Hospital, India Keywords: Drug
More informationWhat s new in EUCAST methods?
What s new in EUCAST methods? Derek Brown EUCAST Scientific Secretary Interactive question 1 MIC determination MH-F broth for broth microdilution testing of fastidious microorganisms Gradient MIC tests
More informationFOLLOWING BUNDLE ADMINISTERED WITHIN ONE HOUR.
Patient label DATE and TIME: 1 REVIEW BY Emergency Department SENIOR REGISTRAR (ED BLEEP 5999) +/-Leave Proforma 2 FOLLOWING BUNDLE ADMINISTERED WITHIN ONE HOUR. Bloods for FBC, U+E, CRP, LFT s, Clotting
More informationCompliance of manufacturers of AST materials and devices with EUCAST guidelines
Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The
More informationAMR Industry Alliance Antibiotic Discharge Targets
AMR Industry Alliance Antibiotic Discharge Targets List of Predicted No-Effect Concentrations (PNECs) The members of the AMR Industry Alliance have developed a unified approach to establishing discharge
More informationA Study on Urinary Tract Infection Pathogen Profile and Their In Vitro Susceptibility to Antimicrobial Agents
Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2017/65 A Study on Urinary Tract Infection Pathogen Profile and Their In Vitro Susceptibility to Antimicrobial Agents M
More informationGuidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults)
Guidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults) Community Acquired Community Acquired 1) Is it pneumonia? ie new symptoms and signs of a lower respiratory
More informationWomen s Antimicrobial Guidelines Summary
Women s Antimicrobial Guidelines Summary 1. Introduction and Who Guideline applies to This guideline has been developed to deliver safe and appropriate empirical use of antibiotics for patients at University
More informationDATA COLLECTION SECTION BY FRONTLINE TEAM. Patient Identifier/ Medical Record number (for facility use only)
Assessment of Appropriateness of ICU Antibiotics (Patient Level Sheet) **Note this is intended for internal purposes only. Please do not return to PQC.** For this assessment, inappropriate antibiotic use
More informationAntimicrobial Stewardship/Statewide Antibiogram. Felicia Matthews Senior Consultant, Pharmacy Specialty BD MedMined Services
Antimicrobial Stewardship/Statewide Antibiogram Felicia Matthews Senior Consultant, Pharmacy Specialty BD MedMined Services Disclosures Employee of BD Corporation MedMined Services Agenda CMS and JCAHO
More informationAntimicrobial Stewardship 101
Antimicrobial Stewardship 101 Betty P. Lee, Pharm.D. Pediatric Infectious Disease/Antimicrobial Stewardship Pharmacist Lucile Packard Children s Hospital Stanford Disclosure I have no actual or potential
More informationa. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.
AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony
More informationEAGAR Importance Rating and Summary of Antibiotic Uses in Humans in Australia
EAGAR Importance Rating and Summary of Antibiotic Uses in Humans in Australia Background The Expert Advisory Group on Antimicrobial Resistance of the NH&MRC provides advice to Australian governments and
More informationPrinciples in antimicrobial therapy: The ABCs
Principles in antimicrobial therapy: The ABCs Benjamin G. Co, MD, FPPS, FPSECP Professorial lecturer in Antimicrobial Therapy, Graduate School University of Santo Tomas Executive Director, Center for Drug
More informationPresenter: Ombeva Malande. Red Cross Children's Hospital Paed ID /University of Cape Town Friday 6 November 2015: Session:- Paediatric ID Update
Emergence of invasive Carbapenem Resistant Enterobacteriaceae CRE infection at RCWMCH Ombeva Oliver Malande, Annerie du Plessis, Colleen Bamford, Brian Eley Presenter: Ombeva Malande Red Cross Children's
More informationDuke University Hospital Guideline for Empiric Inpatient Treatment of Cancer- Related Neutropenic Fever in Adult Patients
Duke University Hospital Guideline for Empiric Inpatient Treatment of Cancer- Related Neutropenic Fever in Adult Patients PURPOSE Fever among neutropenic patients is common and a significant cause of morbidity
More information